Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In humans, clinical data remain limited, but anecdotal reports and early safety studies suggest benefits in soft-tissue recovery and gastrointestinal health
AOD-9604 Administration Guide Proper administration technique ensures optimal absorption, minimizes discomfort, and maintains the peptides stability and efficacy
This product is supplied
You can ask your doctor or pharmacist for a puncture proof disposal container that you can use at home, such as a sharps container, or make your own container
Retatrutide is in Phase 3 clinical trials through Eli Lilly, and cagrilintide is in Phase 3 trials through Novo Nordisk (both as monotherapy and as part of CagriSema)
